Effect of amino groups of mesoporous silica nanoparticles on CpG oligodexynucleotide delivery

References

• KneževićN ŽDurandJ-O 2015 Targeted treatment of cancer with nanotherapeutics based on mesoporous silica nanoparticles ChemPlusChem. 80 26 36 26–36 10.1002/cplu.201402369
   Web of Science ®Google Scholar
• KriegA M 2002 CpG motifs in bacterial DNA and their immune effects Annu. Rev. Immunol. 20 709 760 709–60 10.1146/annurev.immunol.20.100301.064842
   PubMed Web of Science ®Google Scholar
• HanagataN 2012 Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system Int. J. Nanomed. 7 2181 2195 2181–95 10.2147/IJN.S30197
   PubMed Web of Science ®Google Scholar
• KriegA MYiA-KMatsonSWaldschmidtT JBishopG ATeasdaleRKoretzkyG AKlinmanD M 1995 CpG motifs in bacterial DNA trigger direct B-cell activation Nature 374 546 549 546–9 10.1038/374546a0
   PubMed Web of Science ®Google Scholar
• KlinmanD M 2004 Immunotherapeutic uses of CpG oligodeoxynucleotides Nat. Rev. Immunol. 4 249 258 249–58 10.1038/nri1329
   PubMed Web of Science ®Google Scholar
• KriegA M 2006 Therapeutic potential of Toll-like receptor 9 activation Nat. Rev. Drug Discovery 5 471 484 471–84 10.1038/nrd2059
   PubMed Web of Science ®Google Scholar
• MuradY MClayT M 2009 CpG oligodeoxynucleotides as TLR9 agonists: therapeutic applications in cancer Bio. Drugs 23 361 375 361–75 10.2165/11316930-000000000-00000
   Google Scholar
• FonsecaD EKlineJ N 2009 Use of CpG oligonucleotides in treatment of asthma and allergic disease Adv. Drug Delivery Rev. 61 256 262 256–62 10.1016/j.addr.2008.12.007
   PubMed Web of Science ®Google Scholar
• KlinmanD MKlaschikSSatoTTrossD 2009 CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases Adv. Drug Delivery Rev. 61 248 255 248–55 10.1016/j.addr.2008.12.012
   PubMed Web of Science ®Google Scholar
• VollmerJ 2004 Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities Eur. J. Immunol. 34 251 262 251–62 10.1002/eji.200324032
   PubMed Web of Science ®Google Scholar
• SandsHGorey-FeretL JCocuzzaA JHobbsF WChidesterDTrainorG L 1994 Biodistribution and metabolism of internally 3H-labeled oligonucleotides: I. Comparison of a phosphodiester and a phosphorothioate Mol. Pharmacol. 45 932 943 932–43
   PubMed Web of Science ®Google Scholar
• HeikenwalderMPolymenidouMJuntTSigurdsonCWagnerHAkiraSZinkernageR lAguzziA 2004 Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration Nat. Med. 10 187 192 187–92 10.1038/nm987
   PubMed Web of Science ®Google Scholar
• BrownD AKangS-HGryaznovS MDeDionisioLHeidenreichOSullivanSXuXNerenbergM I 1994 Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding J. Biol. Chem. 269 26801 26805 26801–5
   PubMed Web of Science ®Google Scholar
• LevinA A 1999 A review of issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides Biochim. Biophys. Acta. 1489 69 84 69–84 10.1016/S0167-4781(99)00140-2
   PubMed Web of Science ®Google Scholar
• WeiMChenNLiJYinMLiangLHeYSongHFanCHuangQ 2012 Polyvalent immunostimulatory nanoagents with self-assembled CpG oligonucleotide-conjugated gold nanoparticles Angew. Chem. Int. Edn Engl. 51 1202 1206 1202–6 10.1002/anie.201105187
   PubMed Web of Science ®Google Scholar
• TaoYLiZJuERenJQuX 2013 One-step DNA-programmed growth of CpG conjugated silver nanoclusters: a potential platform for simultaneous enhanced immune response and cell imaging Chem. Commun. 49 6918 6920 6918–20 10.1039/c3cc41972j
   PubMed Web of Science ®Google Scholar
• ChenSZhangHChinnathambiSHanagataN 2013 Synthesis of novel chitosan-silica/CpG oligodeoxynucleotide nanohybrids with enhanced delivery efficiency Mater. Sci. Eng. C 33 3382 3388 3382–8 10.1016/j.msec.2013.04.017
   PubMed Web of Science ®Google Scholar
• WangCGongMWuJZhuoRChengS 2014 Dual-functionalized calcium carbonate based gene delivery system for efficient gene delivery RSC Adv. 4 38623 38629 38623–9 10.1039/C4RA05468G
   Web of Science ®Google Scholar
• LiZBarnesJ CBosoyAStoddartJ FZinkJ I 2012 Mesoporous silica nanoparticles in biomedical applications Chem. Soc. Rev. 41 2590 2605 2590–605 10.1039/c1cs15246g
   PubMed Web of Science ®Google Scholar
• ColillaMGonzálezBVallet-RegíM 2013 Mesoporous silica nanoparticles for the design of smart delivery nanodevices Biomater. Sci. 1 114 134 114–34 10.1039/C2BM00085G
   PubMed Web of Science ®Google Scholar
• KresgeC TLeonowiczM ERothW JVartuliJ CBeckJ S 1992 Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism Nature 359 710 712 710–2 10.1038/359710a0
   Web of Science ®Google Scholar
• Vallet-RegiMBalasFArcosD 2007 Mesoporous materials for drug delivery Angew. Chem. Int. Edn Engl. 46 7548 7558 7548–58 10.1002/anie.200604488
   PubMed Web of Science ®Google Scholar
• PasquaA J DSharmaK KShiY LTomsB BOuelletteWDabrowiakJ CAsefaT 2008 Cytotoxicity of mesoporous silica nanomaterials J. Inorg. Biochem. 102 1416 1423 1416–23 10.1016/j.jinorgbio.2007.12.028
   PubMed Web of Science ®Google Scholar
• ChiangY DLianH YLeoS YWangS GYamauchiYWuK C W 2011 Controlling particle size and structural properties of mesoporous silica nanoparticles using the Taguchi method J. Phys. Chem. C 115 13158 13165 13158–65 10.1021/jp201017e
   Web of Science ®Google Scholar
• SuzukiNJiangXRadhakrishnanLNTakaiKShimasakiKHuangY TMiyamotoNYamauchiY 2011 Hybridization of photoactive titania nanoparticles with mesoporous silica nanoparticles and investigation of their photocatalytic activity Bull. Chem. Soc. Japan 84 812 817 812–7 10.1246/bcsj.20110027
   Web of Science ®Google Scholar
• LianH YKaoZ KLiaoY CYamauchiYWuK C W 2013 Self-assembled mesoporous silica nanoparticles in controlled patterns produced by soft-lithography and ink-jet printing J. Nanosci. Nanotechnol. 13 2804 2808 2804–8 10.1166/jnn.2013.7339
   PubMed Web of Science ®Google Scholar
• LinDChengQJiangQHuangYYangZHanSZhaoYGuoSLiangZDongA 2013 Intracellular cleavable poly(2-dimethylaminoethyl methacrylate) functionalized mesoporous silica nanoparticles for efficient siRNA delivery in vitro and in vivo Nanoscale 5 4291 4301 4291–301 10.1039/c3nr00294b
   PubMed Web of Science ®Google Scholar
• DuXXiongLDaiSKleitzFQiaoS 2014 Intracellular microenvironment-responsive dendrimer-like mesoporous nanohybrids for traceable, effective, and safe gene delivery Adv. Funct. Mater. 24 7627 7637 7627–37 10.1002/adfm.201402408
   Web of Science ®Google Scholar
• HomCLuJTamanoiF 2009 Silica nanoparticles as a delivery system for nucleic acid-based reagents J. Mater. Chem. 35 6308 6316 6308–16 10.1039/b904197d
   Web of Science ®Google Scholar
• HartonoS BYuMGuWYangJStrouninaEWangXQiaoSYu CC 2014 Synthesis of multi-functional large pore mesoporous silica nanoparticles as gene carriers Nanotechnology 25 055701 10.1088/0957-4484/25/5/055701
   PubMed Web of Science ®Google Scholar
• KimT HKimMEltohamyMYunY RJangJ HKimH W 2013 Efficacy of mesoporous silica nanoparticles in delivering BMP-2 plasmid DNA for in vitro osteogenic stimulation of mesenchymal stem cells J. Biomed. Mater. Res. A 101 1651 1660 1651–60 10.1002/jbm.a.34466
   PubMed Web of Science ®Google Scholar
• KarMTiwariNTiwariMLahiriMGuptaS S 2013 Poly-L-arginine grafted silica mesoporous nanoparticles for enhanced cellular uptake and their application in DNA delivery and controlled drug release Part. Part. Syst. Charact. 30 166 179 166–79 10.1002/ppsc.201200089
   Web of Science ®Google Scholar
• NishikawaMMatonoMRattanakiatSMatsuokaNTakakuraY 2008 Enhanced immunostimulatory activity of oligodeoxynucleotides by Y-shape formation Immunology 124 247 255 247–55 10.1111/j.1365-2567.2007.02762.x
   PubMed Web of Science ®Google Scholar
• RattanakiatSNishikawaMFunabashiHLuoDTakakuraY 2009 The assembly of a short linear natural cytosine-phosphate-guanine DNA into dendritic structures and its effect on immunostimulatory activity Biomaterials 30 5701 5706 5701–6 10.1016/j.biomaterials.2009.06.053
   PubMed Web of Science ®Google Scholar
• ChinnathambiSChenSGanesanSHanagataN 2012 Binding mode of CpG oligodeoxynucleotides to nanoparticles regulates bifurcated cytokine induction via toll-like receptor 9 Sci. Rep. 2 534 10.1038/srep00534
   PubMed Web of Science ®Google Scholar
• TaoCZhuYLiXHanagataN 2015 Binding of CpG oligodeoxynucleotides to mesoporous silica nanoparticles for enhancing delivery efficiency Micropor. Mesopor. Mater. 204 91 98 91–8 10.1016/j.micromeso.2014.11.007
   Web of Science ®Google Scholar
• JambhrunkarSQuZPopatAYangJNoonanOAcauanLNorY AYuCKarmakarS 2014 Effect of surface functionality of silica nanoparticles on cellular uptake and cytotoxicity Mol. Pharmacol. 10 3642 3655 3642–55 10.1021/mp500385n
   Web of Science ®Google Scholar
• ZhangQNeohK GXuLLuSKangEMahendranRChiongE 2014 Functionalized mesoporous silica nanoparticles with mucoadhesive and sustained drug release properties for potential bladder cancer therapy Langmuir 30 6151 6161 6151–61 10.1021/la500746e
   PubMed Web of Science ®Google Scholar
• TeesD F JWoodwardJ THammerD A 2001 Reliability theory for receptor–ligand bond dissociation J. Chem. Phys. 114 7483 7496 7483–96 10.1063/1.1356030
   Web of Science ®Google Scholar
• MutwiriG KNichaniA KBabiukSBabiukL A 2004 Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides J. Control. Release 97 1 17 1–17 10.1016/j.jconrel.2004.02.022
   PubMed Web of Science ®Google Scholar
• LeeI HKwonH KAnSKimDKimSYuM KLeeJ HLeeT SImS HJonS 2012 Imageable antigen-presenting gold nanoparticle vaccines for effective cancer immunotherapy in vivo Angew. Chem. Int. Edn Engl. 51 8800 8805 8800–5 10.1002/anie.201203193
   PubMed Web of Science ®Google Scholar
• ChenN 2014 Self-assembly of poly-adenine-tailed CpG oligonucleotide-gold nanoparticle nanoconjugates with immunostimulatory activity Small 10 368 375 368–75 10.1002/smll.201300903
   PubMed Web of Science ®Google Scholar
• PrelaudA RFuchsSWeberKWinterGCoesterCMuellerR S 2013 In vitro effects of CpG oligodeoxynucleotides delivered by gelatin nanoparticles on canine peripheral blood mononuclear cells of atopic and healthy dogs—a pilot study Vet. Dermatol 24 494 e117 494–e117 10.1111/vde.12056
   PubMed Web of Science ®Google Scholar
• ZhuYShiJLiYShenWDongXRuanM 2005 Storage and release of ibuprofen drug molecules in hollow mesoporous silica spheres with modified pore surface Micropor. Mesopor. Mater. 85 75 81 75–81 10.1016/j.micromeso.2005.06.015
   Web of Science ®Google Scholar